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1ABSTRACT
Mild malformation of cortical development; clinical feature and surgical outcome related 
to histopathology
Hye Eun Kwon
Department of Medicine
The Graduate School, Yonsei University
(Directed by Professor Heung Dong Kim)
Mild malformation of cortical development (mMCD), which classified by the Palmini et 
al. could not have mature clinical impact until now. This study aimed to show the clinical 
feature and surgical outcome associated with pathological finding, mMCD. Thirty-six of 
children and adolescents who underwent resective epilepsy surgery with confirmed 
mMCD by pathological finding were reviewed. All the patients were medically 
intractable to 2 or more antiepileptic drugs (AEDs) and/or ketogenic diet and were 
followed up for more than 2 years after surgery. Central nervous system comorbidities 
(such as prematurity, asphyxia, bleeding, hydrocephalus, early CNS infection and 
traumatic brain injury) were seen in 9 cases (25.0%). Twenty six cases (72.2%) presented 
as childhood onset epileptic encephalopathy, further divided by 20 Lennox-Gastaut 
syndrome and 6 West syndrome, while 10 cases (27.8%) presented as focal epilepsy (8 
cases; extratemporal lesion, 2 cases; temporal lesion). For the age of seizure onset, 18
cases (50.0%) had started seizure before the age of 1 year, and 22 cases (61.1%) had 
seizures before the age of 2 year. Seventeen cases (47.2%) had non focal MRI 
abnormalities. The most frequent surgical procedure was 22 cases (61.1%) of multilobar 
2resections, followed by 102 cases (27.8%) of unilobar resection, and 4 cases (11.1%) of 
posterior quadrantectomy along with frontal lobectomy. The median postoperative 
followed-up duration was 4.8 years and final surgical outcome including reoperations, 22
cases (61.1%) had Engel I outcome. Six (27.3%) out of 22 Engel I cases were off all the 
AEDs. This study identified mMCD as an important pathologic finding related to 
comparable degree of epileptogenicity and supported the certainty of focal pathology of 
mMCD, could be successfully treated by resective surgery.
------------------------------------------------------------------------------------------------------------
Key words: mild malformation of cortical development, pediatric epilepsy surgery
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I. INTRODUCTION
Recent classification of focal cortical dysplasia (FCD) by International League Against 
Epilepsy (ILAE) has introduced in 2011, 1 and there are changes from the classification 
by Palmini and colleagues. 2,3 One of the important changes is whether mild malformation 
of cortical development (mMCD), which is characterized by normal cortical architecture 
and abundant ectopically placed neurons in or adjacent layer 1 or in the white matters, is a 
subgroup as itself or not. They stated that mMCD should be included in the new ILAE 
FCD classification, although their clinical impact will need further clarification. There are 
few reports about the clinical feature and surgical outcome of mMCD and most reports 
are composed of smaller than 10 cases (Table 1). 4-6
Collectively these reports provide information only for 51 epilepsy surgery cases with 
mMCD, too early for discussing clinical and surgical outcome related to this pathological 
finding. Kasper mentioned about that the clinical feature and surgical outcome of mMCD 
4would be different in terms of whether temporal location or not. 7 Krsek and colleagues 
showed mMCD had a comparable degree of epileptogenicity, and they showed surgery 
outcome on extra temporal cases, but it was the only study that analyzed mMCD outside 
the temporal lobe. 5 Not only, there was discrepancy between the interobserver and 
intraobserver for the pathological result of mMCD 8 but also neurons were 
physiologically present in cerebral white matter, which is particularly pronounced within 
temporal lobe. 9
Over the last decade, this study observed seizure free outcome in mMCD pediatric 
surgical cases, and the goal of this study was to analyze our a lot of experience with 
mMCD cases in order to contribute to the clinical feature and surgical outcome of mMCD.
Table 1. Summary of previous publications on surgical treatment of patients with mMCD 
Study mMCD/all cases 
(%)
Years Most frequent 
procedure
Engel class
I + II (%)
Fauser et al. 8/67 (11.9) 1998-2003 Temporal resection 63+25=88
Krsek et al. 36 /200 (18.0) 1986-2006 Lobar resection 52+6=58
Mühlebner et al. 7 /50 (14.0) 2000-2013 Lesionectomy 71+15=86
.  
5II. MATERIALS AND METHODS
1. Patients
We identified 36 patients pathologically confirmed as mMCD at Severance Children’s 
Hospital from September 2003 and to April 2013. All the patients were medically 
intractable to 2 or more antiepileptic drugs (AEDs) and/or ketogenic diet and were 
followed up for more than 2 years after surgery. 
2. Clinical characteristics and diagnostic work-up 
Clinical features such as seizure onset age, age at surgery, epilepsy duration, AEDs prior 
to surgery, clinical spectrum of epilepsy and baseline developmental function were 
reviewed. Pre-operative cognitive function were tested using a neuropsychological scale 
by a psychologist or global development assessment by care takers. Developmental 
function was measured using age-appropriated standardized instruments, such as Korean-
Wechsler intelligence scales for children (K-WISC) and Korean-Wechsler adults 
intelligence scales (K-WAIS) or the Bayley scales for infant development. Mental 
retardation (MR) was defined as a measured or estimated FSIQ <70. 
Presurgical evaluations always included long-term video EEG monitoring, MRI and 
FDG-PET. Selected cases also underwent additional diagnostic tests including fMRI, 
diffusion tensor imaging and fiber tractography (DTI-FT) and interictal/ictal SPECT, 
according to feasibility; evaluation of these results was not included in this study. 
3. Seizure outcomes
Seizure outcomes were annually assessed from outpatient visit and were classified 
6according to both Engel’s classification scheme 10 and ILAE epilepsy surgery outcome 
evaluation. 11
4. Neuropathological analysis 
Brain tissue was analyzed at the department of pathology. Pathologist classified mMCD 
by Palmini et al with careful reevaluation. 2,3
5. Statistical analysis
Kaplan-Meier survival analysis was used to calculate the probability of seizure freedom.
Statistical analyses were done using SPSS version 18.0. 
7III. RESULTS
1. Demographic data and clinical profile
Demographic data and clinical profile are summarized in Table 2. All cases were children 
or adolescents. Twenty six cases (72.2%) presented as childhood onset epileptic 
encephalopathy (EE), further divided by 20 Lennox-Gastaut syndrome (LGS) and 6 West 
syndrome, while 10 cases (27.8%) presented as focal epilepsy (8 cases; extratemporal 
lesion, 2 cases; temporal lesion). Among the 20 LGS cases, 16 evolved from West 
syndrome and only 4 cases started with LGS. 77.8% of patients were suffered from daily 
seizure. 
Central nervous system comorbidities (such as prematurity, asphyxia, bleeding, 
hydrocephalus, early CNS infection and traumatic brain injury) were seen in 9 cases 
(25.0%). MR before surgery was observed in 32 cases (88.9%). The median of seizure 
onset age was 1.0 year, 18 cases (50.0%) had started seizure before the age of 1 year, and 
22 cases (61.1%) had seizures before the age of 2 year. The median of epilepsy duration
was 5.0 years and patients had median number of 3 AEDs, 2 to 4 AEDs trials before 
surgery. Ketogenic diet was tried in 22 cases (61.1%).
8Table 2. Demographic data and clinical profile
Characteristic N (%)
Gender Male/Female 19 (52.8)/17 (47.2)
Under 18 years 36 (100.0)
Clinical spectrum of epilepsy Epileptic encephalopathy 
LGS/ West syndrome
Focal epilepsy
26 (72.2)
20 (55.6)/6 (16.7)
10 (27.8)
Extra-temporal/temporal lesion 8 (22.2)/2 (5.6)
Seizure frequency Patients with daily seizures 28 (77.8)
CNS comorbidity 9 (25.0)
MR before surgery 32 (88.9)
History of ketogenic diet 22 (61.1)
Median (interquartile range)
Age at seizure onset, y 1.0 (0.4-5.8)
Age at surgery, y 7.4 (3.6-12.5)
Epilepsy duration, y 5.0 (1.4-7.1)
Follow up duration, y 4.8 (3.4-7.5)
No. of AEDs 3.0 (2.0-4.0)
Abbreviations: LGS=Lennox-Gastaut syndrome; CNS=central nervous system; MR= 
mental retardation; AEDs=antiepileptic drugs
92. MRI findings
MRI features of the mMCD are summarized in Table 3. Sixteen cases (44.4%) had 
normal MRI scans. MRI abnormalities for cortical malformations were identified in 19
cases (52.8%) and diffuse brain atrophy was observed in 1 case (2.8%). Blurring of the
gray/white matter junction was the most frequent feature, occurring in 12 cases (33.3%). 
White matter signal abnormality in FLAIR or T2 weighted was encountered in 11 cases 
(30.6 %) [increased signal change in 9 subjects (25.0%), decreased signal change in 2 
(5.6%) )], whereas gray matter signal change in FLAIR or T2 weighted was observed in 6 
cases (16.7%). Lobar hypoplasia/atrophy was observed in 1 patient (2.8%). 
Table 3. MRI findings 
Characteristic N (%)
Normal MRI 16 (44.4)
Other MRI abnormality (Diffuse brain atrophy) 1 (2.8)
MRI feature for cortical malformations 19 (52.8)
Individual MRI feature of mMCD
Blurring of the gray/white matter junction 12 (33.3)
White matter signal abnormality in FLAIR or T2 weighted 11 (30.6)
Increased /decreased signal change 9 (25.0) /2 (5.6)
Gray matter increased signal abnormality in FLAIR or T2 weighted 6 (16.7)
Lobar hypoplasia/atrophy 1 (2.8)
Abbreviations: mMCD=mild malformation of cortical development
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3. EEG findings 
Long-term video EEG monitoring findings were presented in Table 4. There was no case 
who had a normal interictal EEG result. Slow background activity was seen in 29 cases 
(80.6%), and focal/lateralized asymmetric slowing was observed in 27 cases (75.0%). 
EEG findings, characterized by secondary generalized epileptic encephalopathy, such as 
hypsarrhythmia, generalized slow spike-wave complexes, and generalized paroxysmal 
fast activities, and electrodecrements were seen in 26 cases (72.2 %). Secondary bilateral 
synchrony was seen in 4 cases (11.1%). Focal or unilateral excitable EEG findings, such 
as spindle shaped fast activities, localized paroxysmal fast activities, brief ictal rhythmic 
discharges, focal subclinical seizure activities and repetitive rhythmic spike and wave 
discharges were seen in 23 cases (63.9%). We classified as EEG asymmetry in long term 
video EEG result, when it was included focal slowing, focal or unilateral excitable EEG 
findings, lateralized spike or sharp waves, or localized spike or sharp waves. Thirty one 
cases (86.1%) showed EEG asymmetry. And EEG asymmetric lesions were always 
concordant to surgical resection site.  
11
Table 4. EEG findings
EEG characteristics N (%)
Normal interictal EEG 0
Slow background 29 (80.6)
Focal or lateralized slowing 27 (75.0)
Secondary bilateral synchrony 4 (11.1)
GSSW, GPFA, electrodecrements /Hypsarrhythmia 20 (55.6) /6 (16.2)
Focal or unilateral excitable EEG findings a 23 (63.9)
EEG asymmetry 31 (86.1)
a Such as spindle shaped fast activities, localized paroxysmal fast activities, brief ictal 
rhythmic discharges, focal subclinical seizure activities and repetitive rhythmic spike and 
wave discharges were seen
Abbreviations: GSSW =generalized slow spike and wave discharges; GPFA=generalized 
paroxysmal fast activities 
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4. PET findings 
All patients underwent FDG-PET scan. In 10 cases, we identified no signs of focal hypo-
or hypermetabolism, whereas 2 cases showed diffuse hypometabolic area. FDG-PET and 
MRI abnormalities overlapped in the remaining cases; The relationship between FDG-
PET and MRI abnormalities is specified in Table 5. There were 11 cases (30.6%) in 
whom the lesion was not detected in the MRI but in the PET, further divided by 6 cases 
were localized in same resection area and 5 cases were lateralized in same hemisphere. 
Table 5. PET findings 
PET findings N (%)
No abnormality 10 (27.8)
Localized 17 (47.2)
Lateralized 7 (19.4)
Multifocal 2 (5.6)
MRI positive, PET negative 4 (11.1)
PET positive, MRI negative 11 (30.6)
MRI and PET negative 6 (16.7)
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5. Surgical procedures 
Surgical procedures are presented in Table 6. In terms of surgical procedures, 22 cases
(61.1%) underwent multilobar resections (exceeding 1 lobar boundary), followed by 10
cases (27.8%) of unilobar resection, and 4 cases (11.1%) of posterior quadrantectomy 
along with frontal lobectomy. 
As complications, 12 cases (33.3%) had morbidity and there was no mortality. 
Complications were included subdural hematoma (4 cases), weakness (3 cases), and 
wound infection (2 cases) and an impairment of visual field, venous infarction, and 
hydrocephalus in each 1 case. 
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Table 6. Surgical procedures in mMCD patients 
Characteristic N (%)
Median age at (first) surgery, y 7.4
Callostomy before resective surgery 6 (16.7)
Surgical procedure Unilobar resection 10 (27.8)
Multilobar resection 22 (61.1)
Frontal resection+ PQ 4 (11.1)
Number of reoperation patients 5 (13.9)
mMCD location Left /right 16/20 (44.1/55.6)
Frontal (F) 8 (22.2)
Temporal (T) 2 (5.6)
Parietal (P) 0 
Occipital (O) 0 
Multilobar 26 (72.2) 
FT/FP/ FTP/FTO 15/1/1/1
TO/TPO 1/2
FTPO (subtotal hemispherectomy) 5
Abbreviations: mMCD=mild malformation of cortical development; PQ=posterior 
quadrantectomy 
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6. Seizure outcome 
The median postoperative followed-up duration was 4.8 years interquarter-ranged from 
3.4 years to 7.5 years. As final surgical outcome including reoperations, 22 cases (61.1%) 
were Engel I, 1 case (2.8%) were categorized as Engel II, 2 cases (5.6%) as Engel III and 
11 cases (30.6%) as Engel IV. At last follow up, 27.3% (6/22) of Engel I were off all 
AEDs. Seizure outcome by ILAE was also determined. 8 Overall, 63.9 % (n=23) of cases 
are classified in either Engel I or II (free from or rare disabling seizures) and comparably,
we classified 61.1% (n=22) as ILAE 1-3 (only auras or 1-3 seizure days per year). Thus, 
these showed similar pattern of surgical outcomes. 
A Kaplan-Meier survival plot showed that seizure free rates after surgery dropped within 
2 years, which reflected early recurrence of seizures, as shown in Figure 1. 10 patients 
were initially seizure free after the operation, but had recurred seizures during the follow 
up. In depth analysis of 11 surgery procedures (1 patient had re-operations), 4 procedures 
(36.4%) had seizure recurrence within a year, followed by 3 procedures (27.3%) between 
1 to 2 years, and 4 (36.4%) remote recurrence 2 years after the surgery.
16
Figure 1. Kaplan-Meier curve showing long term postoperative outcome 
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7. Analysis of the “Surgical failure”
10 cases who did not become seizure free received additional examinations which always 
included prolonged EEG recording for minimum of 4 hours and MRI; 70.0% (7/10) had 
postoperative seizure onset arose from the operated hemisphere. The other 30.0% (3/10) 
cases showed uncertain seizure onset area because of lack of ictal seizure capture. 
Therefore, incomplete resection was the most likely explanation for continuing seizures 
in mMCD cases. 
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8. Reoperation 
Reoperation was performed in 5 cases, which always included more extended resection 
adjacent to the previous operative lesion. The clinical characteristics and surgery outcome 
were shown in Table 7. They showed no focal abnormality in preoperative MRI finding, 
except 1 case. The surgery outcome of first operation was as follows; 3 cases were Engel 
IV, and other 2 cases were Engel I at first but recurred seizure later on. After the 
reoperation, 2 cases (40.0%) obtained seizure free outcome and among the other 3 cases, 
2 cases were remained seizure free for 1 year, but recurred seizure during the AEDs 
reduction. 
Table 7. Characteristics and surgery outcome of re-operated cases 
Cases Age at 1st/2nd
surgery  
Epilepsy 
syndrome 
Pre-op MRI Location of 
1st/2nd surgery 
Engel 
class 
1 3.5/4.4 LGS Diffuse brain atrophy F/F-P IV
2 4.5/5.4 FE Abnormality F/Insula I-> IV
3 5.4/6.6 FE No abnormality F/F-PQ I ->IV
4 13.3/16.2 LGS No abnormality T/T-P I
5 15.4/22.1 FE No abnormality F/F-T I
Abbreviations: op=operation; LGS=Lennox-Gastaut syndrome; FE=Focal epilepsy; 
F=frontal; P=parietal; PQ=posterior quadrantectomy; T=temporal 
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9. Patients who had performed corpus callostomy prior to resective surgery
Six cases (16.7%) had palliative surgical procedure, corpus callosotomy (CC) before 
resective surgery due to lack of focality in presurgical evaluations. Following CC, phase 
1 presurgical evaluation was performed repeatedly in all 6 cases. All these patients were 
suffered from EE. Changes of post callosotomy presurgical evaluation results were 
observed. Lateralized EEG findings were observed in 4 cases, PET along with EEG 
findings or cerebral blood flows along with EEG findings in each 1 case were obtained. 
These findings were helpful in delineating the primary seizure focus in 4 LGS and 2 West 
syndrome cases. The clinical characteristics and surgical outcome in these patients were 
shown in Table 8. 
Table 8. Characteristics and surgery outcome of corpus callosotomy cases
Cases Age at cc/rec. 
surgery  
Epilepsy 
syndrome 
Pre-op 
MRI 
Changes after CC 
finding 
Engel 
class 
1 2.3/2.9 WS Suspicious EEG I
2 3.4/3.6 WS->LGS Suspicious EEG I
3 4.5/4.9 LGS Suspicious EEG, PET I
4 4.7/5.0 LGS Negative EEG IV
5 7.5/8.9 LGS Negative EEG, Interictal SPECT I
6 9.1/12.1 LGS Suspicious EEG I
Abbreviations: cc=corpus callosotomy; rec.=resective; op=operation; WS=West syndrome ; 
LGS=Lennox-Gastaut syndrome 
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IV. DISCUSSION
This study is the first of composed of the largest number of patients focusing on the 
clinical features and surgical outcome of mMCD. Especially for pediatric intractable 
epilepsy, pediatric epilepsy surgery has had an attention and performed more frequently 
in the last decade. However, there was still limited number of surgical cases with 
childhood onset EE with negative MRI lesion. Because in infants and young children, 
localized brain lesion could produce generalized EEG abnormalities and generalized 
seizures which are specific childhood onset EE, such as West syndrome and LGS. 12,13
Although, this study could conduct the clinical feature of high proportion of childhood 
onset EE without definite MRI lesion associated with mMCD. As a result, mMCD was 
accounting for 33% of pathologically diagnosed as FCD at our center.
For the clinical implication, early report questioned about the certainty of mMCD with 
negative MRI finding. 7 Fauser and colleagues reported that the clinical severity was 
milder than other form of pathology such as FCD type II, and they showed success rate of 
63% of seizure freedom. 6 As their cases were located in temporal lobe, the clinical 
severity and surgical outcome might be biased by the high rate of temporal resection. 
However, we believe our pediatric mMCD cases are clinically different from the reported 
cases of temporal locations of Fauser et al.
This study showed mMCD presented as early onset of seizure, 72.2% of childhood onset 
EE, wider distribution of pathology presented as surgical extent and high rate of MR 
before surgery. That is, even mildly dysplastic features in pathology, mMCD is highly
epileptogenic. And, these features are very distinct from adult focal epilepsy as noted by 
circumscribed and well located FCD pathology. Krsek and colleagues who only identified 
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mMCD as an important pathological finding related to comparable degree of 
epileptogenicity and showed 52% of seizure free outcome in pediatrics resective epilepsy 
surgery. 5 Similarly, our result showed slightly better outcome as 61.1% of seizure 
freedom. Thus, these result supported the certainty of pathology of mMCD, also surgery 
outcome supported that mMCD as a focal pathology. 
For the treatment strategy, the median epilepsy duration was 5.0 years and 61.1% of 
patients tried ketogenic diet before surgery. It can be infer that surgical plan might be not 
an early option but a last resort in this patient group. As less opportunity of surgery, 
mMCD was uncovered as both at pathological level and clinical profiles. This study also 
revealed that even patients who had EE with negative MRI finding successfully gained 
66.7% (8/12) of Engel I outcome. In these cases, the plan for surgery is based on cortical 
abnormality detected by focal EEG findings revealed by long term video EEG result and 
FDG-PET, neurological exam and other presurgical evaluations. With regarding 
secondary generalized EE, where most epileptiform discharges are generalized, long term 
video EEG result showed prominent localization or lateralized abnormalities, side 
appropriated for surgery in this surgery. Among the 26 EE cases, there were 12 cases had 
negative MRI findings in this study. And these cases were helped surgery plan by EEG 
asymmetry (10 cases), or FDG-PET (8 cases). In addition, this study described 6 cases 
who had a prior callosotomy, then had become candidate for respective surgery. High rate 
of Engel I outcome (83.3%) was observed in these patients .This finding showed that 
callosotomy was helpful to identify for epileptic foci.14,15 Thus, challenging but highly 
problematic patients, who had lack of evidence of focal lesion at a glance, but after 
careful presurgical evaluation or callosotomy, they could become candidate for resective 
surgery. 
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For the MRI finding, there was only one report of MRI features of mMCD. 5 In 
agreement with previous report, blurring of the gray-white matter junction was the most 
common abnormality and as high as 47.2% of negative MRI finding. 5 And other typical 
cortical abnormalities of FCD was also observed in mMCD, but known features of FCD 
type II such as increased cortical thickness, abnormal gyral/sulcal patterns, and 
transmantle sign are features were never observed. 5 Thus, demarcation of mMCD was far 
more difficult comparing than previously reported MRI feature of FCD type II.
This study observed that the CNS comorbidities could be associated with mMCD. Krsek 
and colleagues mentioned the pathogenic relationship between mild form of cortical 
malformation with acquired brain lesion. 5,16,17 They explained that mMCD with known 
prenatal and perinatal brain injury exhibited a higher frequency of abnormal neurologic 
findings, low IQ scores, higher incidence of slow EEG background activity, which could 
be explained by the presence of wide spread cortical and subcortical brain injury. 17 In 
addition, Marin-Padilla stated that early onset insult caused a phenomenon recently 
described as “progressive cortical dysplasia”. 18 Although, we excluded mMCD with 
definite destructive brain lesion in MRI scan, this study showed similar proportions of 
CNS comorbidity. Thus, it will be able to show stronger evidence for the association with 
the CNS comorbidity and mMCD, when including definite destructive brain in MRI 
findings.
Long term postoperative outcome analyzed that 63.6 % of seizure relapse occurred during 
the first and second year. This result shows that it is also important to follow–up patients, 
since seizure may recur up to 4.3 years after the surgery. In a depth analysis of 
postoperative investigations by long term EEG result, all cases who became not seizure 
23
free had seizures still arose from the same hemisphere. Regarding the reoperation
outcome, 4 of 5 cases regained Engel I outcome for a year, but 2 of them showed 
recurrence of seizure during the AEDs reduction. Thus, surgical failures in our series 
were caused, therefore, rather by incomplete resection of dysplastic cortex than by 
epileptogenic area located in the opposite hemisphere, the other studies supported as well.
19,20
24
V. CONCLUSION
This study identified mMCD as an important pathologic finding related to comparable 
degree of epileptogenicity and supported the certainty of focal pathology of mMCD, 
could be successfully treated by resective surgery. 
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Abstract (In Korean)
Mild malformation of cortical development 의 임상 양상 및 수술 성적 고찰
<지도교수 김흥동>
연세대학교 대학원 의학과
권혜은
Mild malformation of cortical development (mMCD) 의 임상 양상에 대한
조사는 희박하여 본 연구는 mMCD 의 임상 양상 및 뇌전증 수술 성적을
조사하였다. 세브란스 어린이 병원에서 수술 후 병리소견에서 mMCD 로
진단된 37명의 환자를 대상으로 하였다. 환자들은 수술 전 2가지 이상의 항
경련제 또는 케톤생성 식이요법에도 불구하고 발작이 충분이 조절되지 않았고
수술 후 최소 2년 이상의 평가 기간을 가졌다. 과거력에서 미숙아, 뇌출혈, 
수두증, 중추 신경계 감염 및 외상성 뇌손상의 빈도는 9명에서 확인되었다. 
73.0%의 환자는 레녹스 가스토 증후군(21명) 및 웨스트 증후군 (6명)의
간질성 뇌병증 양상으로 분류되었고 나머지 27.0%는 부분 뇌전증으로 8명의
외측두엽 뇌전증과 2명의 측두엽 뇌전증으로 구분되었다. 전체 환자의
48.6%에서 발작이 1세 이전, 59.5%에서 2세 이전에 발작이 시작하였고
45.9%는 뇌 자기공명영상에서 이상 소견이 확인되지 않았다. 수술 방법은
다엽 절제술이 22명 (45.9%) 으로 가장 많았다. 수술 후 평균 4.9년 추적
관찰을 통해 23명(62.2%)의 환자는 발작이 조절되었으며 이들 중 7명의
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환자는 항 경련제를 중단할 수 있었다. 이러한 결과로 미루어 mMCD 는
뇌전증을 유발할 수 있는 질병으로서 수술적 방법을 통해 성공적으로 치료 될
수 있다.  
---------------------------------------------------------------------------------------------------------------------
핵심이 되는 말: mild malformation of cortical development, 소아 뇌전증 수술
